Records containing: Schizophrenia
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-01-02Improving Cognition Through Telehealth Aerobic Exercise and Cognitive Training After a First Schizophrenia Episode
-
CLINICAL_TRIALS study record update · 2024-12-27A Four-week, Multicentre, Double-blinded, Randomised, Active- and Placebo- Controlled, Parallel-group Trial Investigating Efficacy and Safety of Cannabidiol in Acute, Early-stage Schizophrenic Patients
-
CLINICAL_TRIALS study record update · 2024-12-27The Impact of Aripiprazole Long-acting on Myelin and Cognition in the Onset of Schizophrenia
-
CLINICAL_TRIALS study record update · 2024-12-27Open-Label Study in Stable Schizophrenia Patients to Evaluate the Safety, Tolerability, and Pharmacokinetics of Switching From Oral Risperidone to Risperidone Implant (DLP-114)
-
CLINICAL_TRIALS study record update · 2024-12-19Phase 3, Randomized, 28 Days, Double-blind, Placebo-controlled, Multicenter Study to Assess the Safety and Efficacy of Brilaroxazine (RP5063) in Subjects With Schizophrenia, Followed by a 52-Week Open-label Extension
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2024-12-18Motivation Skills Training to Enhance Functional Outcomes for People With Schizophrenia (Open Trial)
-
CLINICAL_TRIALS study record update · 2024-12-17Impact of A Low-Carbohydrate, High-Fat, Ketogenic Diet on Obesity, Metabolic Abnormalities and Psychiatric Symptoms in Patients With Bipolar or Schizophrenia Illness: A Pilot Trial
-
CLINICAL_TRIALS study record update · 2024-12-17The Clinical and Functional Imaging Effects of Non-invasive Neuromodulation on Illness Awareness in Schizophrenia
-
CLINICAL_TRIALS study record update · 2024-12-16Imaging Synapses With [11C] UCB-J in the Human Brain
-
CLINICAL_TRIALS study record update · 2024-12-16An Open-label Extension Study to Assess the Safety and Tolerability of SEP-363856 in Subjects With Schizophrenia
-
CLINICAL_TRIALS study record update · 2024-12-13Personalized Repetitive Transcranial Magnetic Stimulation for Patients with Refractory Schizophrenia: an Open-label Study
-
CLINICAL_TRIALS study record update · 2024-12-13A Randomized, Double-blind, Placebo- and Active-controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of Iloperidone in Schizophrenic Patients in Acute Exacerbation Followed by a Long-term Treatment Phase.
-
CLINICAL_TRIALS study record update · 2024-12-12Dual-channel Transcranial Alternating Current Stimulations Targeting Negative Symptoms in Schizophrenia Patients: a Randomized Clinical Trial
-
CLINICAL_TRIALS study record update · 2024-12-12Mental Health During the Whole Life Cycle of Community Patients with Schizophrenia: a Cohort Study
-
CLINICAL_TRIALS study record update · 2024-12-10Randomized Double Blind Placebo Controlled Study of Ondansetron and Simvastatis Added to Treatment As Usual in Patients with Schizophrenia
-
CLINICAL_TRIALS study record update · 2024-12-09Identification of a Serotonin 2A Receptor Subtype of Schizophrenia Spectrum Disorders With Pimavanserin: The Sub-Sero Proof-of-principle Study
-
CLINICAL_TRIALS study record update · 2024-12-09A Phase 3, Randomized, Double-blind, Parallel-group, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of KarXT in Acutely Psychotic Hospitalized Adults With DSM-5 Schizophrenia
-
CLINICAL_TRIALS study record update · 2024-12-09The Effect of Auditory Hallucination-based Sound Simulation Application That is Listened to by Caregivers of Individuals with Schizophrenia on Their Emotional Expression and Perceived Family Burden
-
CLINICAL_TRIALS study record update · 2024-12-09Study of Multimodal Intra- and Interpersonal Synchronizations in Social Interaction in Individuals with a Diagnosis of Schizophrenia.
-
CLINICAL_TRIALS study record update · 2024-12-09Neural Correlates of Social Touch and Interoceptive Perception As Potential Biomarker for Impaired Social Functioning
-
CLINICAL_TRIALS study record update · 2024-12-09Leveraging Integrated Models of Care to Improve Patient-Centered Outcomes for Publicly-Insured Adults With Complex Health Care Needs
-
CLINICAL_TRIALS study record update · 2024-12-06Context-Aware Mobile Intervention for Social Recovery in Serious Mental Illness
-
CLINICAL_TRIALS study record update · 2024-12-05Melatonin Metabolism Abnormality in Patients With Schizophrenia or Schizoaffective Disorder Treated With Olanzapine and Melatonin Dose Finding for the Correction of the Metabolic Abnormality
-
CLINICAL_TRIALS study record update · 2024-12-04A First in Human Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Oral Doses of KYN-5356 in Adult, Healthy Subjects
-
CLINICAL_TRIALS study record update · 2024-11-25An Open-Label Positron Emission Tomography Study to Investigate the Effect of Adjunctive Administration of SEP-363856 on Brain Dopamine Synthesis Capacity Using 18F-DOPA in Adult Subjects With Schizophrenia